Why Protein Intake Is Crucial for GLP-1 Users
Imagine this: You’ve been on a GLP-1 for a few months. The scale has shifted in a direction you had hoped and even your clothes are beginning to fit better. Your friends are noticing! But you noticed your energy dips during the day in a way that doesn’t feel like hunger (2) or maybe you […]
STAT+: Pharmalittle: We’re reading about Novo Nordisk layoffs, an Amgen discount program, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a good start here on the Pharmalot campus, where we have cool breezes and sunny skies are greeting us. Who could ask for anything more? Actually, we could — it is time to reheat the coffee kettle for another […]
Insilico’s AI Workflow Has Two Jobs: Discover Compounds, Thwart Competitors
A preprint posted by researchers at artificial intelligence (AI)-based drug developer Insilico Medicine plots a two-pronged roadmap that aims to address two key questions in drug discovery: How can companies efficiently search the universe of more than 10⁶⁰ potential drug molecules for new treatments? And how can those companies prevent their discoveries from being the […]
The Great Alzheimer’s Scam and the Proven Cures They’ve Buried for Billions
One of the least appreciated aspects of medicine is the numerous frameworks that have been developed to understand how the body works and how to heal it. This, I believe is a result of conventional medicine having successfully branded itself as the one true path to understanding the body and each remaining approach being a […]
This popular retailer now sells Ozempic with an additional discount
The chain’s pharmacy is offering GLP-1 weight-loss drugs nationwide, along with a 2%-off perk for certain customers. Some good news on the weight-loss front: Customers can now go to Costco to get Ozempic and Wegovy, brand-name injectable prescription drugs manufactured by drug maker Novo Nordisk, which contain the same active ingredient: semaglutide.
Skye Bio Obesity Drug Fails in Phase 2; Hopes Now Ride on Higher Doses and Combo Treatment
While Skye Bioscience said its drug nimacimab may yet achieve better weight loss results with higher doses, the company and analysts are interested in the drug’s potential to be combined with Novo Nordisk’s Wegovy. Skye’s drug is an antibody designed to preferentially target CB1 receptors in the gut, offering an alternative approach to activating GLP-1 […]
Evolv launches peptide that engages GLP-1 receptors as new ‘biomimetics’ category emerges
Multiple ingredients from prebiotic fibers to bacteria are claimed to trigger the production of appetite-regulating hormones such as GLP-1. But they don’t have the same effects as drugs that linger in the body for days, says Evolv cofounder Becca McCarthy. San Francisco-based Evolv, she says, is targeting the sweet spot between these two options with Evolv […]
Wegovy and Zepbound should be the go-to obesity treatment, medical group says
The new guidelines are yet another sign that GLP-1 drugs like Ozempic are likely to continue soaring in popularity as a weight loss treatment
JM Smucker to spend over $120M on Hostess plant expansion
The Twinkies owner was acquired two years ago for $5.6 billion, but has since seen demand wane amid inflation and an uptick in the use of GLP-1 drugs.
Danone CMO Linda Bethea on re-engineering marketing for GLP-1 era
The multinational food and beverage brand’s chief marketer for North America shares how it is using AI, retail media and protein-rich innovation to adapt to consumers who are eating less – but expecting more. Linda Bethea has built brands across household-name companies and categories. Today, as CMO at Danone North America, she is pairing the […]